Jo Cox

Jo is a pharmaceutical physician with more than 20 years’ experience in the industry, in clinical development, medical affairs, and pharmacovigilance. Jo has worked in a number of different therapy areas, with a particular focus on Women’s Health

Jo’s clinical background is in obstetrics and gynaecology, primarily in the UK NHS, and 2 years spent in Australia. On joining Lilly, Jo worked in medical affairs on the women’s health portfolio, diabetes, urology and cardiovascular therapy areas, including product launches.

Jo’s experience in pharmacovigilance spans early and late phase development, she was safety lead on regulatory submission activities in US, Japan and Europe. Before joining tranScrip, Jo was the medical lead on a global phase 3 study in early breast cancer. In addition, Jo has recruited and managed medical teams of physicians, clinical research scientists and medical science liaisons.

Jo is a member of the Royal College of Obstetricians and Gynaecologists, and a member of the Faculty of Pharmaceutical Medicine’s Expert Group in Paediatrics and Women’s Health.